{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:03:27Z","timestamp":1787025807801,"version":"build-2736575974"},"reference-count":50,"publisher":"Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,28]]},"DOI":"10.31744\/einstein_journal\/2026ao2153","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T13:46:32Z","timestamp":1780062392000},"source":"Crossref","is-referenced-by-count":1,"title":["Immunoexpression of stem cell markers CD44, CD133, ALDH1-2, and LGR5 in colorectal carcinoma and their association with clinicopathological tumor characteristics"],"prefix":"10.31744","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9368-1399","authenticated-orcid":false,"given":"Karine Corcione","family":"Turke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1086-4247","authenticated-orcid":false,"given":"Cinthia dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6210-6917","authenticated-orcid":false,"given":"Carla","family":"Pagliari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7425-5925","authenticated-orcid":false,"given":"Giovanna Maria Gimenez","family":"Testa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0498-2622","authenticated-orcid":false,"given":"Th\u00e9r\u00e8se Rachell","family":"Theodoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8669-3562","authenticated-orcid":false,"given":"Bianca","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2775-8068","authenticated-orcid":false,"given":"Jaques","family":"Waisberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16942","reference":[{"issue":"5","key":"key20260529134629_B1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/omi.2021.0025","article-title":"Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression\/Evasion, Drug Resistance, Epithelial-Mesenchymal Transition, and Metastasis","volume":"25","author":"Dzobo","year":"2021","unstructured":"1 Dzobo K, Sinkala M. Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression\/Evasion, Drug Resistance, Epithelial-Mesenchymal Transition, and Metastasis. OMICS. 2021;25(5):313-32.","journal-title":"OMICS"},{"issue":"1","key":"key20260529134629_B2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/dvdy.434","article-title":"Morphogen regulation of stem cell plasticity in intestinal regeneration and carcinogenesis","volume":"251","author":"Eggington","year":"2022","unstructured":"2 Eggington HR, Mulholland EJ, Leedham SJ. Morphogen regulation of stem cell plasticity in intestinal regeneration and carcinogenesis. Dev Dyn. 2022;251(1):61-74.","journal-title":"Dev Dyn"},{"issue":"5","key":"key20260529134629_B3","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/cas.16117","article-title":"Cell cycle heterogeneity and plasticity of colorectal cancer stem cells","volume":"115","author":"Higa","year":"2024","unstructured":"3 Higa T, Nakayama KI. Cell cycle heterogeneity and plasticity of colorectal cancer stem cells. Cancer Sci. 2024;115(5):1370-7.","journal-title":"Cancer Sci"},{"issue":"8","key":"key20260529134629_B4","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.21873\/anticanres.14453","article-title":"Clinical Implications of Cancer Stem Cell Markers and ABC Transporters as a Predictor of Prognosis in Colorectal Cancer Patients","volume":"40","author":"Kim","year":"2020","unstructured":"4 Kim BH, Oh HK, Kim DW, Kang SB, Choi Y, Shin E. Clinical Implications of Cancer Stem Cell Markers and ABC Transporters as a Predictor of Prognosis in Colorectal Cancer Patients. Anticancer Res. 2020;40(8):4481-9.","journal-title":"Anticancer Res"},{"issue":"2","key":"key20260529134629_B5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3390\/genes14020481","article-title":"TCF7L1 Regulates LGR5 Expression in Colorectal Cancer Cells","volume":"14","author":"King","year":"2023","unstructured":"5 King CM, Marx OM, Ding W, Koltun WA, Yochum GS. TCF7L1 Regulates LGR5 Expression in Colorectal Cancer Cells. Genes (Basel). 2023;14(2):481.","journal-title":"Genes (Basel)"},{"issue":"5","key":"key20260529134629_B6","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.153793","article-title":"Disruption of the crypt niche promotes outgrowth of mutated colorectal tumor stem cells","volume":"7","author":"Klingler","year":"2022","unstructured":"6 Klingler S, Hsu KS, Hua G, Martin ML, Adileh M, Baslan T, et al. Disruption of the crypt niche promotes outgrowth of mutated colorectal tumor stem cells. JCI Insight. 2022;7(5):e153793.","journal-title":"JCI Insight"},{"issue":"7","key":"key20260529134629_B7","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.3390\/ijms26072890","article-title":"Patient-Derived Colorectal Cancer Extracellular Matrices Modulate Cancer Cell Stemness Markers","volume":"26","author":"Marques-Magalh\u00e3es","year":"2025","unstructured":"7 Marques-Magalh\u00e3es \u00c2, Monteiro-Ferreira S, Can\u00e3o PA, Rios E, Costa \u00c2M, Castro F, et al. Patient-Derived Colorectal Cancer Extracellular Matrices Modulate Cancer Cell Stemness Markers. Int J Mol Sci. 2025;26(7):2890.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"key20260529134629_B8","doi-asserted-by":"crossref","first-page":"15605","DOI":"10.1096\/fj.202001329R","article-title":"LGR5 constitutively activates NF-\u03baB signaling to regulate the growth of intestinal crypts","volume":"34","author":"Lai","year":"2020","unstructured":"8 Lai S, Cheng R, Gao D, Chen YG, Deng C. LGR5 constitutively activates NF-\u03baB signaling to regulate the growth of intestinal crypts. FASEB J. 2020;34(11):15605-20.","journal-title":"FASEB J"},{"issue":"10","key":"key20260529134629_B9","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3390\/cells14100686","article-title":"The TIP60-CD44 Axis Modulates Colorectal Cancer Stemness","volume":"14","author":"Mohammad","year":"2025","unstructured":"9 Mohammad A, Jha S. The TIP60-CD44 Axis Modulates Colorectal Cancer Stemness. Cells. 2025;14(10):686.","journal-title":"Cells"},{"issue":"1","key":"key20260529134629_B10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.47162\/RJME.62.1.11","article-title":"Pathological and immunohistochemical study of colon cancer. Evaluation of markers for colon cancer stem cells","volume":"62","author":"Ilie","year":"2021","unstructured":"10 Ilie DS, Mitroi G, P\u0103un I, \u0162enea-Cojan T\u015e, Neam\u0163u C, Totolici BD, et al. Pathological and immunohistochemical study of colon cancer. Evaluation of markers for colon cancer stem cells. Rom J Morphol Embryol. 2021;62(1):117-24.","journal-title":"Rom J Morphol Embryol"},{"issue":"18","key":"key20260529134629_B11","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2174\/0113816128291321240329050945","article-title":"Colorectal Cancer Stem Cell Biomarkers: Biological Traits and Prognostic Insights","volume":"30","author":"Soleimani","year":"2024","unstructured":"11 Soleimani A, Saeedi N, Al-Asady AM, Nazari E, Hanaie R, Khazaei M, et al. Colorectal Cancer Stem Cell Biomarkers: Biological Traits and Prognostic Insights. Curr Pharm Des. 2024;30(18):1386-97.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"key20260529134629_B12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10555-024-10239-x","article-title":"LGR5: an emerging therapeutic target for cancer metastasis and chemotherapy resistance","volume":"44","author":"Wang","year":"2025","unstructured":"12 Wang W, Lokman NA, Barry SC, Oehler MK, Ricciardelli C. LGR5: an emerging therapeutic target for cancer metastasis and chemotherapy resistance. Cancer Metastasis Rev. 2025;44(1):23.","journal-title":"Cancer Metastasis Rev"},{"issue":"5-6","key":"key20260529134629_B13","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1002\/jcb.29600","article-title":"Exosomes from CD133+ cells carrying circ-ABCC1 mediate cell stemness and metastasis in colorectal cancer","volume":"121","author":"Zhao","year":"2020","unstructured":"13 Zhao H, Chen S, Fu Q. Exosomes from CD133+ cells carrying circ-ABCC1 mediate cell stemness and metastasis in colorectal cancer. J Cell Biochem. 2020;121(5-6):3286-97.","journal-title":"J Cell Biochem"},{"issue":"2","key":"key20260529134629_B14","doi-asserted-by":"crossref","DOI":"10.1590\/0102-672020210002e1585","article-title":"Are stem cell Marker expression and cd133 analysis relevant to differentiate colorectal Cancer?","volume":"34","author":"Czeczko","year":"2021","unstructured":"14 Czeczko LE, Ribas CA, Czeczko NG, Skare TL, Yamakawa CK, Gionedis G, et al. Are stem cell Marker expression and cd133 analysis relevant to differentiate colorectal Cancer? Arq Bras Cir Dig. 2021;34(2):e1585.","journal-title":"Arq Bras Cir Dig"},{"key":"key20260529134629_B15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbrc.2020.09.005","article-title":"Phenotype-based single cell sequencing identifies diverse genetic subclones in CD133 positive cancer stem cells","volume":"558","author":"Min","year":"2021","unstructured":"15 Min DW, Kim HP, Kim J, Wen X, Kim S, Cho YW, et al. Phenotype-based single cell sequencing identifies diverse genetic subclones in CD133 positive cancer stem cells. Biochem Biophys Res Commun. 2021;558:209-15.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"key20260529134629_B16","first-page":"402","article-title":"Association between CD133 expression and clinicopathological profile in colorectal cancer","volume":"17","author":"Rey","year":"2020","unstructured":"16 Rey I, Putra A, Lindarto D, Yusuf F. Association between CD133 expression and clinicopathological profile in colorectal cancer. Med Glas. 2020;17(2):402-7.","journal-title":"Med Glas"},{"issue":"10","key":"key20260529134629_B17","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.3390\/ijms26104740","article-title":"CD133 Expression in Circulating Tumor Cells as a Prognostic Marker in Colorectal Cancer","volume":"26","author":"Sawai","year":"2025","unstructured":"17 Sawai K, Koneri K, Kimura Y, Goi T. CD133 Expression in Circulating Tumor Cells as a Prognostic Marker in Colorectal Cancer. Int J Mol Sci. 2025;26(10):4740.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"key20260529134629_B18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10517-024-06026-x","article-title":"A Validation Study of CD133 as a Reliable Marker for Identification of Colorectal Cancer Stem-Like Cells","volume":"176","author":"You","year":"2024","unstructured":"18 You CZ, Xu H, Zhao FS, Dou J. A Validation Study of CD133 as a Reliable Marker for Identification of Colorectal Cancer Stem-Like Cells. Bull Exp Biol Med. 2024;176(3):369-75.","journal-title":"Bull Exp Biol Med"},{"key":"key20260529134629_B19","doi-asserted-by":"crossref","first-page":"104125","DOI":"10.1016\/j.ebiom.2022.104125","article-title":"Single-cell sequencing reveals CD133+CD44--originating evolution and novel stemness related variants in human colorectal cancer","volume":"82","author":"Zhang","year":"2022","unstructured":"19 Zhang X, Yang L, Lei W, Hou Q, Huang M, Zhou R, et al. Single-cell sequencing reveals CD133+CD44--originating evolution and novel stemness related variants in human colorectal cancer. EBioMedicine. 2022;82:104125.","journal-title":"EBioMedicine"},{"key":"key20260529134629_B20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2021.01.022","article-title":"Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo","volume":"331","author":"Andrade","year":"2021","unstructured":"20 Andrade F, Rafael D, Vilar-Hern\u00e1ndez M, Montero S, Mart\u00ednez-Trucharte F, Seras-Franzoso J, et al. Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo. J Control Release. 2021;331:198-212.","journal-title":"J Control Release"},{"issue":"1","key":"key20260529134629_B21","doi-asserted-by":"crossref","first-page":"2195363","DOI":"10.1080\/15384047.2023.2195363","article-title":"The v8-10 variant isoform of CD44 is selectively expressed in the normal human colonic stem cell niche and frequently is overexpressed in colon carcinomas during tumor development","volume":"24","author":"Boman","year":"2023","unstructured":"21 Boman BM, Viswanathan V, Facey CO, Fields JZ, Stave JW. The v8-10 variant isoform of CD44 is selectively expressed in the normal human colonic stem cell niche and frequently is overexpressed in colon carcinomas during tumor development. Cancer Biol Ther. 2023;24(1):2195363.","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"key20260529134629_B22","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.3390\/ijms23042180","article-title":"CD44 Expression Intensity Marks Colorectal Cancer Cell Subpopulations with Different Extracellular Vesicle Release Capacity","volume":"23","author":"Kelemen","year":"2022","unstructured":"22 Kelemen A, Carmi I, Seress I, L\u0151rincz P, T\u00f6lgyes T, Dede K, et al. CD44 Expression Intensity Marks Colorectal Cancer Cell Subpopulations with Different Extracellular Vesicle Release Capacity. Int J Mol Sci. 2022; 23(4):2180.","journal-title":"Int J Mol Sci"},{"key":"key20260529134629_B23","doi-asserted-by":"crossref","first-page":"147896","DOI":"10.1016\/j.gene.2023.147896","article-title":"Expression of CD44 is regulated by ELF3 in 5-FU treated colorectal cancer cells","volume":"892","author":"Li","year":"2024","unstructured":"23 Li F, Qiu F, Fan X, Yu Q, Liu S, Guo Y, et al. Expression of CD44 is regulated by ELF3 in 5-FU treated colorectal cancer cells. Gene. 2024;892:147896.","journal-title":"Gene"},{"issue":"1","key":"key20260529134629_B24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10517-022-05512-4","article-title":"Expression of CD44 Isoforms in Tumor Samples and Cell Lines of Human Colorectal Cancer","volume":"173","author":"Novosad","year":"2022","unstructured":"24 Novosad VO, Polikanova IS, Tonevitsky EA, Maltseva DV. Expression of CD44 Isoforms in Tumor Samples and Cell Lines of Human Colorectal Cancer. Bull Exp Biol Med. 2022;173(1):155-9.","journal-title":"Bull Exp Biol Med"},{"issue":"1","key":"key20260529134629_B25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/ijms26010251","article-title":"The Significance of Aldehyde Dehydrogenase 1 in Cancers","volume":"26","author":"Nguyen","year":"2024","unstructured":"25 Nguyen AL, Facey CO, Boman BM. The Significance of Aldehyde Dehydrogenase 1 in Cancers. Int J Mol Sci. 2024;26(1):251.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"key20260529134629_B26","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.apsb.2021.02.008","article-title":"The role of ALDH2 in tumorigenesis and tumor progression: targeting ALDH2 as a potential cancer treatment","volume":"11","author":"Zhang","year":"2021","unstructured":"26 Zhang H, Fu L. The role of ALDH2 in tumorigenesis and tumor progression: targeting ALDH2 as a potential cancer treatment. Acta Pharm Sin B. 2021; 11(6):1400-11.","journal-title":"Acta Pharm Sin B"},{"key":"key20260529134629_B27","doi-asserted-by":"crossref","first-page":"110175","DOI":"10.1016\/j.cbi.2022.110175","article-title":"Proteomic profiling reveals an association between ALDH and oxidative phosphorylation and DNA damage repair pathways in human colon adenocarcinoma stem cells","volume":"368","author":"Wang","year":"2022","unstructured":"27 Wang Y, Chen Y, Garcia-Milian R, Golla JP, Charkoftaki G, Lam TT, et al. Proteomic profiling reveals an association between ALDH and oxidative phosphorylation and DNA damage repair pathways in human colon adenocarcinoma stem cells. Chem Biol Interact. 2022;368:110175.","journal-title":"Chem Biol Interact"},{"issue":"1","key":"key20260529134629_B28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3390\/ijms23010403","article-title":"Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients","volume":"23","author":"AbdelMageed","year":"2021","unstructured":"28 AbdelMageed M, Ismail HT, Olsson L, Lindmark G, Hammarstr\u00f6m ML, Hammarstr\u00f6m S, et al. Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients. Int J Mol Sci. 2021;23(1):403.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"key20260529134629_B29","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3390\/medicina59071233","article-title":"The Expression of Stem Cell Marker LGR5 and Its Coexpression with B-Catenin in Sporadic Colorectal Carcinoma and Adenoma: A Comparative Immunohistochemical Study","volume":"59","author":"Ahmed","year":"2023","unstructured":"29 Ahmed EM, Farag AS, Abdelwahed MS, Hanbazazh M, Samman A, Ashmawy D, et al. The Expression of Stem Cell Marker LGR5 and Its Coexpression with B-Catenin in Sporadic Colorectal Carcinoma and Adenoma: A Comparative Immunohistochemical Study. Medicina (Kaunas). 2023;59(7):1233.","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"key20260529134629_B30","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1038\/s41467-024-47227-2","article-title":"Membrane to cortex attachment determines different mechanical phenotypes in LGR5+ and LGR5- colorectal cancer cells","volume":"15","author":"Conti","year":"2024","unstructured":"30 Conti S, Venturini V, Ca\u00f1ellas-Socias A, Cortina C, Abenza JF, Stephan-Otto Attolini C, et al. Membrane to cortex attachment determines different mechanical phenotypes in LGR5+ and LGR5- colorectal cancer cells. Nat Commun. 2024;15(1):3363.","journal-title":"Nat Commun"},{"issue":"5","key":"key20260529134629_B31","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000353","article-title":"Colon Crypts of Subjects With Familial Adenomatous Polyposis Show an Increased Number of LGR5+ Ectopic Stem Cells","volume":"12","author":"Jennelle","year":"2021","unstructured":"31 Jennelle LT, Dampier CH, Tring S, Powell S, Casey G. Colon Crypts of Subjects With Familial Adenomatous Polyposis Show an Increased Number of LGR5+ Ectopic Stem Cells. Clin Transl Gastroenterol. 2021;12(5):e00353.","journal-title":"Clin Transl Gastroenterol"},{"issue":"22","key":"key20260529134629_B32","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.3390\/cells12222658","article-title":"LGR5 Expression Predicting Poor Prognosis Is Negatively Correlated with WNT5A in Colon Cancer","volume":"12","author":"Mehdawi","year":"2023","unstructured":"32 Mehdawi LM, Ghatak S, Chakraborty P, Sj\u00f6lander A, Andersson T. LGR5 Expression Predicting Poor Prognosis Is Negatively Correlated with WNT5A in Colon Cancer. Cells. 2023;12(22):2658.","journal-title":"Cells"},{"issue":"4","key":"key20260529134629_B33","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/jcmm.17164","article-title":"LRP5 promotes cancer stem cell traits and chemoresistance in colorectal cancer","volume":"26","author":"Nie","year":"2022","unstructured":"33 Nie X, Liu H, Ye W, Wei X, Fan L, Ma H, et al. LRP5 promotes cancer stem cell traits and chemoresistance in colorectal cancer. J Cell Mol Med. 2022;26(4):1095-112.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"key20260529134629_B34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/PAI.0000000000000983","article-title":"Prognostic Impact of LGR5, Prox1, and Notch1 Biomarkers in Stage II to III Colon Cancer","volume":"30","author":"Abdelrahman","year":"2022","unstructured":"34 Abdelrahman AE, El-Azony A, Elsebai E, Ibrahim HM. Prognostic Impact of LGR5, Prox1, and Notch1 Biomarkers in Stage II to III Colon Cancer. Appl Immunohistochem Mol Morphol. 2022;30(2):126-35.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"10","key":"key20260529134629_B35","doi-asserted-by":"crossref","first-page":"6369","DOI":"10.1245\/s10434-024-15783-y","article-title":"Defining Colorectal Cancer Cells on a Single Cell Level Reveals LGR5+ Proliferative Stem Cell Expression in Peritoneal Metastasis","volume":"31","author":"Nee","year":"2024","unstructured":"35 Nee K, Hosohama L, Alobuia W, Kim AC, Senthil M, Eng OS. Defining Colorectal Cancer Cells on a Single Cell Level Reveals LGR5+ Proliferative Stem Cell Expression in Peritoneal Metastasis. Ann Surg Oncol. 2024;31(10):6369-72.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"key20260529134629_B36","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1007\/s00268-020-05586-z","article-title":"Stem Cell Marker Expression in Early Stage Colorectal Cancer is Associated with Recurrent Intestinal Neoplasia","volume":"44","author":"Walker","year":"2020","unstructured":"36 Walker BS, Zarour LR, Wieghard N, Gallagher AC, Swain JR, Weinmann S, et al. Stem Cell Marker Expression in Early Stage Colorectal Cancer is Associated with Recurrent Intestinal Neoplasia. World J Surg. 2020;44(10):3501-9.","journal-title":"World J Surg"},{"issue":"4","key":"key20260529134629_B37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277395","article-title":"Less demand on stem cell marker-positive cancer cells may characterize metastasis of colon cancer","volume":"18","author":"Kaida","year":"2023","unstructured":"37 Kaida T, Fujiyama Y, Soeno T, Yokota M, Nakamoto S, Goto T, et al. Less demand on stem cell marker-positive cancer cells may characterize metastasis of colon cancer. PLoS One. 2023;18(4):e0277395.","journal-title":"PLoS One"},{"issue":"11","key":"key20260529134629_B38","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.1245\/s10434-023-13849-x","article-title":"Cancer Stem Cells Persist Despite Cellular Damage, Emergence of the Refractory Cell Population","volume":"30","author":"Nagae","year":"2023","unstructured":"38 Nagae A, Miyoshi N, Fujino S, Horie M, Yachida S, Sasaki M, et al. Cancer Stem Cells Persist Despite Cellular Damage, Emergence of the Refractory Cell Population. Ann Surg Oncol. 2023;30(11):6913-24.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"key20260529134629_B39","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1158\/1535-7163.MCT-22-0415","article-title":"Loss of LGR5 through Therapy-induced Downregulation or Gene Ablation Is Associated with Resistance and Enhanced MET-STAT3 Signaling in Colorectal Cancer Cells","volume":"22","author":"Posey","year":"2023","unstructured":"39 Posey TA, Jacob J, Parkhurst A, Subramanian S, Francisco LE, Liang Z, et al. Loss of LGR5 through Therapy-induced Downregulation or Gene Ablation Is Associated with Resistance and Enhanced MET-STAT3 Signaling in Colorectal Cancer Cells. Mol Cancer Ther. 2023;22(5):667-78.","journal-title":"Mol Cancer Ther"},{"key":"key20260529134629_B40","doi-asserted-by":"crossref","first-page":"121541","DOI":"10.1016\/j.lfs.2023.121541","article-title":"Targeting aldehyde dehydrogenase enzymes in combination with chemotherapy and immunotherapy: an approach to tackle resistance in cancer cells","volume":"320","author":"Al-Shamma","year":"2023","unstructured":"40 Al-Shamma SA, Zaher DM, Hersi F, Abu Jayab NN, Omar HA. Targeting aldehyde dehydrogenase enzymes in combination with chemotherapy and immunotherapy: an approach to tackle resistance in cancer cells. Life Sci. 2023;320:121541.","journal-title":"Life Sci"},{"key":"key20260529134629_B41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-3-319-09614-8_16","article-title":"Acetaldehyde and retinaldehyde-metabolizing enzymes in colon and pancreatic cancers","volume":"815","author":"Singh","year":"2015","unstructured":"41 Singh S, Arcaroli J, Thompson DC, Messersmith W, Vasiliou V. Acetaldehyde and retinaldehyde-metabolizing enzymes in colon and pancreatic cancers. Adv Exp Med Biol. 2015;815:281-94.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"key20260529134629_B42","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s12029-019-00295-w","article-title":"The Expression Analysis of Intestinal Cancer Stem Cell Marker Lgr5 in Colorectal Cancer Patients and the Correlation with Histopathological Markers","volume":"51","author":"Salehzadeh","year":"2020","unstructured":"42 Salehzadeh S, Hasanzad M, Kadijani AA, Akbari A. The Expression Analysis of Intestinal Cancer Stem Cell Marker Lgr5 in Colorectal Cancer Patients and the Correlation with Histopathological Markers. J Gastrointest Cancer. 2020;51(2):591-9.","journal-title":"J Gastrointest Cancer"},{"key":"key20260529134629_B43","doi-asserted-by":"crossref","first-page":"151739","DOI":"10.1016\/j.anndiagpath.2021.151739","article-title":"Inverse correlation between PD-L1 expression and LGR5 expression in tumor budding of stage II\/III colorectal cancer","volume":"52","author":"Sato","year":"2021","unstructured":"43 Sato K, Uehara T, Nakajima T, Iwaya M, Miyagawa Y, Watanabe T, et al. Inverse correlation between PD-L1 expression and LGR5 expression in tumor budding of stage II\/III colorectal cancer. Ann Diagn Pathol. 2021;52:151739.","journal-title":"Ann Diagn Pathol"},{"issue":"6","key":"key20260529134629_B44","first-page":"587","article-title":"Cancer stem cell markers CD44v9+\/CD133- are associated with low apoptosis in both sporadic and ulcerative colitis-associated colorectal cancers","volume":"37","author":"Nakagomi","year":"2022","unstructured":"44 Nakagomi E, Mikami T, Funahashi K, Okazumi S, Shibuya K, Hiruta N, et al. Cancer stem cell markers CD44v9+\/CD133- are associated with low apoptosis in both sporadic and ulcerative colitis-associated colorectal cancers. Histol Histopathol. 2022;37(6):587-95.","journal-title":"Histol Histopathol"},{"issue":"20","key":"key20260529134629_B45","doi-asserted-by":"crossref","first-page":"11201","DOI":"10.3390\/ijms252011201","article-title":"Interconnection of CD133 Stem Cell Marker with Autophagy and Apoptosis in Colorectal Cancer","volume":"25","author":"Sipos","year":"2024","unstructured":"45 Sipos F, M\u0171zes G. Interconnection of CD133 Stem Cell Marker with Autophagy and Apoptosis in Colorectal Cancer. Int J Mol Sci. 2024;25(20):11201.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"key20260529134629_B46","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/stmcls\/sxae060","article-title":"CD44: a stemness driver, regulator, and marker-all in one?","volume":"42","author":"Sonnentag","year":"2024","unstructured":"46 Sonnentag SJ, Ibrahim NS, Orian-Rousseau V. CD44: a stemness driver, regulator, and marker-all in one? Stem Cells. 2024;42(12):1031-9.","journal-title":"Stem Cells"},{"issue":"8","key":"key20260529134629_B47","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41416-025-02968-9","article-title":"CD44+ cells enhance pro-tumor stroma in the spatial landscape of colorectal cancer leading edge","volume":"132","author":"Tang","year":"2025","unstructured":"47 Tang F, Zhu Y, Shen J, Yuan B, He X, Tian Y, et al. CD44+ cells enhance pro-tumor stroma in the spatial landscape of colorectal cancer leading edge. Br J Cancer. 2025;132(8):703-15.","journal-title":"Br J Cancer"},{"issue":"7","key":"key20260529134629_B48","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1111\/jcmm.17221","article-title":"siRNA-induced CD44 knockdown suppresses the proliferation and invasion of colorectal cancer stem cells through inhibiting epithelial-mesenchymal transition","volume":"26","author":"Zou","year":"2022","unstructured":"48 Zou W, Zhang Y, Bai G, Zhuang J, Wei L, Wang Z, et al. siRNA-induced CD44 knockdown suppresses the proliferation and invasion of colorectal cancer stem cells through inhibiting epithelial-mesenchymal transition. J Cell Mol Med. 2022;26(7):1969-78.","journal-title":"J Cell Mol Med"},{"issue":"8","key":"key20260529134629_B49","first-page":"1213.e8","article-title":"Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasia","volume":"29","author":"Vasquez","year":"2022","unstructured":"49 Vasquez EG, Nasreddin N, Valbuena GN, Mulholland EJ, Belnoue-Davis HL, Eggington HR, et al. Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasia. Cell Stem Cell. 2022;29(8):1213-1228.e8.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"key20260529134629_B50","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12943-025-02265-2","article-title":"Cancer stem cells and niches: challenges in immunotherapy resistance","volume":"24","author":"Pan","year":"2025","unstructured":"50 Pan Y, Yuan C, Zeng C, Sun C, Xia L, Wang G, et al. Cancer stem cells and niches: challenges in immunotherapy resistance. Mol Cancer. 2025;24(1):52.","journal-title":"Mol Cancer"}],"container-title":["einstein (S\u00e3o Paulo)"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T13:46:39Z","timestamp":1780062399000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.einstein.br\/article\/immunoexpression-of-stem-cell-markers-cd44-cd133-aldh1-2-and-lgr5-in-colorectal-carcinoma-and-their-association-with-clinicopathological-tumor-characteristics\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":50,"alternative-id":["10.31744\/einstein_journal\/2026AO2153"],"URL":"https:\/\/doi.org\/10.31744\/einstein_journal\/2026ao2153","relation":{},"ISSN":["1679-4508","2317-6385"],"issn-type":[{"value":"1679-4508","type":"print"},{"value":"2317-6385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"eAO2153"}}